Cao M - Search Results

1

TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA.

Zhang S, Cao M, Yan S, Liu Y, Fan W, Cui Y, Tian F, Gu R, Cui Y, Zhan Y, Sun Y, Xing Y, Cai L, Song Y. Zhang S, et al. Among authors: cao m. Int J Biol Sci. 2022 Apr 18;18(7):2962-2979. doi: 10.7150/ijbs.71283. eCollection 2022. Int J Biol Sci. 2022. PMID: 35541909 Free PMC article.

2

MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells.

Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L, Gemma A. Cao M, et al. Int J Oncol. 2012 Sep;41(3):869-75. doi: 10.3892/ijo.2012.1535. Epub 2012 Jun 28. Int J Oncol. 2012. PMID: 22752005 Free PMC article.

3

Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.

Zhao Y, Wang H, Li X, Cao M, Lu H, Meng Q, Pang H, Li H, Nadolny C, Dong X, Cai L. Zhao Y, et al. Among authors: cao m. J Cell Physiol. 2014 Nov;229(11):1855-62. doi: 10.1002/jcp.24639. J Cell Physiol. 2014. PMID: 24692224

4

MiR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells.

Cao M, Li Y, Lu H, Meng Q, Wang L, Cai L, Dong X. Cao M, et al. J Cancer Res Clin Oncol. 2014 Oct;140(10):1661-70. doi: 10.1007/s00432-014-1725-0. Epub 2014 Jun 5. J Cancer Res Clin Oncol. 2014. PMID: 24898878

5

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin.

Chen X, Jiang Y, Huang Z, Li D, Chen X, Cao M, Meng Q, Pang H, Sun L, Zhao Y, Cai L. Chen X, et al. Among authors: cao m. Sci Rep. 2016 Jan 19;6:19455. doi: 10.1038/srep19455. Sci Rep. 2016. PMID: 26781643 Free PMC article.

6

NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers.

Wang X, Yin H, Zhang H, Hu J, Lu H, Li C, Cao M, Yan S, Cai L. Wang X, et al. Among authors: cao m. Cell Death Dis. 2018 Apr 1;9(4):418. doi: 10.1038/s41419-018-0447-7. Cell Death Dis. 2018. PMID: 29549343 Free PMC article.

7

USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma.

Zhang H, Han B, Lu H, Zhao Y, Chen X, Meng Q, Cao M, Cai L, Hu J. Zhang H, et al. Among authors: cao m. Cancer Lett. 2018 Oct 1;433:186-198. doi: 10.1016/j.canlet.2018.07.002. Epub 2018 Jul 4. Cancer Lett. 2018. PMID: 29981430

8

TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.

Xing Y, Liu Y, Liu T, Meng Q, Lu H, Liu W, Hu J, Li C, Cao M, Yan S, Huang J, Wang T, Cai L. Xing Y, et al. Among authors: cao m. Cell Commun Signal. 2018 Jul 31;16(1):43. doi: 10.1186/s12964-018-0254-x. Cell Commun Signal. 2018. PMID: 30064446 Free PMC article.

9

Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.

Huang J, Lan X, Wang T, Lu H, Cao M, Yan S, Cui Y, Jia D, Cai L, Xing Y. Huang J, et al. Among authors: cao m. Oncogene. 2020 Feb;39(8):1739-1755. doi: 10.1038/s41388-019-1099-5. Epub 2019 Nov 18. Oncogene. 2020. PMID: 31740781

10

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy.

Song Y, Yan S, Fan W, Zhang M, Liu W, Lu H, Cao M, Hao C, Chen L, Tian F, Zhan Y, Cai L, Xing Y. Song Y, et al. Among authors: cao m. Front Cell Dev Biol. 2020 Jul 3;8:550. doi: 10.3389/fcell.2020.00550. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32719796 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,654 results

Search Page

Filters